How to Support Hair Health During GLP-1 Weight Loss
Treatment with galanin or apelin, which are both peptides released in the intestine, results in decreased duodenal contraction via the ENS, which subsequently signals to the hypothalamus, leading to increased hypothalamic NO release and whole-body glucose utilization 79,80
The triple agonist combination or triagonist as they call it will be able to manipulate metabolism in ways we could never imagine
12,29 Furthermore, a significant negative correlation between adiposity and caecal butyrate and propionate concentrations has also been reported in germ-free mice receiving faecal transplants from human twin donors discordant for obesity
A peptide like retatrutide, with its triple agonist activity (GLP-1, GIP, glucagon), can deliver powerful effects, yet this very potency requires that the dosing remain measured and carefully managed
The follow-up pivotal trial (METAOD006 / OPTIONS) enrolled a larger cohort and failed to replicate statistically significant weight loss, which led Metabolic Pharmaceuticals to halt the formal drug development program in 2007
